Signal2026-07-16
EPO Patents

[EPO] T CELL RECEPTOR THAT SPECIFICALLY RECOGNIZES EBV ANTIGEN PEPTIDE, IMMUNE CELL PREPARED THEREFROM, AND USE THEREOF

Part of

Engineered T Cell Immunotherapy Advances